Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation 2021 first-quarter financial results and corporate update conference call. [Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions]. I would now like to hand the conference to your speaker host today, Pam Murphy.
Please go ahead.
Investor Relations Consultant
Thank you, and good morning. On the call from Arbutus executive team are Bill Collier, president and chief executive officer; Dave Hastings, chief financial officer; Dr. Gaston Picchio, chief development officer; and Dr. Mike Sofia, chief scientific officer.
Bill will begin with the review of the first quarter s accomplishment, clinical development, and remaining 2021 corporate objectives; followed by Dave Hastings, who will provide a the review of the company s first quarter financial results. We ll then open up the call for Q&A. Mike and Gaston will be available to